Get the Stockscreener App
2.64
8.65%
-0.25
After Hours:
2.64
Biomea Fusion Inc Stock (BMEA) Latest News
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biomea Fusion reports inducement grant under Nasdaq listing rule - TipRanks
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Biomea Fusion Says Franco Valle Resigns As CFO -February 28, 2025 at 04:16 pm EST - Marketscreener.com
Biomea Fusion to Unveil New Icovamenib Data at the 18th - GlobeNewswire
Biomea Fusion to Unveil New Icovamenib Data at the 18th International Conference on Advanced Technologies & Treatments for Diabetes - The Manila Times
Can This Diabetes Drug Work Long After You Stop Taking It? Biomea's Surprising Clinical Results - StockTitan
Biomea Fusion, Inc. (BMEA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Biomea Fusion stock hits 52-week low at $3.22 amid market challenges - Investing.com India
Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Drops By 12.6% - MarketBeat
Biomea Fusion, Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsBMEA - ACCESS Newswire
Promising US Penny Stocks To Watch In February 2025 - Simply Wall St
SG Americas Securities LLC Takes Position in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Insider Buyers Lose Additional US$78k As Biomea Fusion Dips To US$126m - Simply Wall St
Biomea Fusion stock hits 52-week low at $3.58 amid sharp decline - MSN
Biomea Fusion stock hits 52-week low at $3.58 amid sharp decline By Investing.com - Investing.com South Africa
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives $39.36 Average Price Target from Brokerages - MarketBeat
Biomea Fusion Inc (BMEA) Stock: A Look at the Analyst Recommendations - The News Heater
Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 6.2% - MarketBeat
Biomea Fusion, Inc. (NASDAQ:BMEA) is a favorite amongst institutional investors who own 51% - Yahoo Finance
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Barclays PLC Purchases 24,162 Shares of Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
HC Wainwright Reaffirms Buy Rating for Biomea Fusion (NASDAQ:BMEA) - MarketBeat
Biomea Fusion to Become a Diabetes & Obesity Medicines Company - GlobeNewswire
Biomea Fusion Pivots to Diabetes Focus After Breakthrough Drug Shows 1.5% HbA1c Reduction - StockTitan
Biomea Fusion (NASDAQ:BMEA) Earns “Buy” Rating from D. Boral Capital - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Average Rating of “Buy” from Analysts - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Average Rating of "Buy" by Analysts - MarketBeat
Biomea Fusion's (BMEA) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
Recent uptick might appease Biomea Fusion, Inc. (NASDAQ:BMEA) institutional owners after losing 75% over the past year - Simply Wall St
BMEABiomea Fusion, Inc. Latest Stock News & Market Updates - StockTitan
Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study - GlobeNewswire
Biomea's Icovamenib Boosts Semaglutide Effects: 11.5% Extra Weight Loss, 43% More Muscle Mass - StockTitan
10 Best Diabetes Stocks To Buy Under $10 - Insider Monkey
Here’s Why Biomea Fusion, Inc. (NASDAQ:BMEA) Is Among the Best Diabetes Stocks to Buy Under $10 - Insider Monkey
Biomea Fusion to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Biomea Fusion CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Geode Capital Management LLC Raises Holdings in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Barclays PLC Increases Stock Position in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Short Interest Update - Defense World
State Street Corp Decreases Stock Position in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Biomea Fusion (BMEA) – Analysts’ Weekly Ratings Changes - Defense World
Biomea Fusion Advances Diabetes Treatment with Positive Study Results - TipRanks
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):